Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics
GET POWR RATINGS... FREE!
ORMP Stock Price Chart Interactive Chart >
ORMP Price/Volume Stats
| Current price | $2.08 | 52-week high | $13.73 |
| Prev. close | $2.05 | 52-week low | $1.81 |
| Day low | $2.03 | Volume | 1,245,800 |
| Day high | $2.13 | Avg. volume | 3,184,969 |
| 50-day MA | $6.76 | Dividend yield | N/A |
| 200-day MA | $6.74 | Market Cap | 81.36M |
Oramed Pharmaceuticals Inc. (ORMP) Company Bio
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.
Latest ORMP News From Around the Web
Below are the latest news stories about ORAMED PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ORMP as an investment opportunity.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Is Down -83.87% So Far This Year. Analysts Expect A Significant Price RallyOramed Pharmaceuticals Inc. (NASDAQ:ORMP) price closed higher on Friday, January 27, jumping 0.52% above its previous close. A look at the daily price movement shows that the last close reads $1.93, with intraday deals fluctuated between $1.89 and $1.955. The company’s 5Y monthly beta was ticking 2.32. Taking into account the 52-week price action we … Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Is Down -83.87% So Far This Year. Analysts Expect A Significant Price Rally Read More » |
Surprising stocks: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP -6.31%), Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 6.50%)ORMP has seen its SMA50 which is now -75.75%. In looking the SMA 200 we see that the stock has seen a -72.34%. CTXR has seen its SMA50 which is … The post Surprising stocks: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP -6.31%), Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 6.50%) appeared first on Stocks Equity . |
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP): Buy, Sell Or Hold At $1.93?In last trading session, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) saw 2.2 million shares changing hands with its beta currently measuring 2.08. Company’s recent per share price level of $1.93 trading at -$0.13 or -6.31% at ring of the bell on the day assigns it a market valuation of $77.30M. That closing price of ORMP’s stock is … Oramed Pharmaceuticals Inc. (NASDAQ:ORMP): Buy, Sell Or Hold At $1.93? Read More » |
Pleasing stocks: Siyata Mobile Inc. (NASDAQ:SYTA -2.53%), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP 0.98%)SYTA has seen its SMA50 which is now 1.05%. In looking the SMA 200 we see that the stock has seen a -72.59%. ORMP has seen its SMA50 which is … The post Pleasing stocks: Siyata Mobile Inc. (NASDAQ:SYTA -2.53%), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP 0.98%) appeared first on Stocks Equity . |
ORMP: ORA-D-013-1 Failed To Meet Endpoints; Ending T2D Oral Insulin EffortsBy M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Oramed Pharmaceuticals’ (NASDAQ:ORMP) recently released top-line results from its ORA-D-013-1 Phase 3 study comparing the efficacy of ORMD-0801 to placebo in patients with T2D (type 2 diabetes) at 26 weeks failed to meet primary and secondary endpoints. Oramed expects to discontinue its oral insulin clinical activities for T2D. This |
ORMP Price Returns
| 1-mo | -79.61% |
| 3-mo | -72.45% |
| 6-mo | -78.06% |
| 1-year | -83.17% |
| 3-year | -58.57% |
| 5-year | -73.06% |
| YTD | -82.71% |
| 2022 | -15.76% |
| 2021 | 236.79% |
| 2020 | -17.67% |
| 2019 | 71.67% |
| 2018 | -66.67% |
Continue Researching ORMP
Want to see what other sources are saying about Oramed Pharmaceuticals Inc's financials and stock price? Try the links below:Oramed Pharmaceuticals Inc (ORMP) Stock Price | Nasdaq
Oramed Pharmaceuticals Inc (ORMP) Stock Quote, History and News - Yahoo Finance
Oramed Pharmaceuticals Inc (ORMP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...